[exh101agreement001.jpg]
Exhibit 10.1 EXECUTION COPY 4350823.8 __________________________ FINJAN
HOLDINGS, INC. ___________________________ SERIES A-1 PREFERRED STOCK PURCHASE
AGREEMENT ___________________________ June 15, 2017 ___________________________

--------------------------------------------------------------------------------

 
[exh101agreement002.jpg]
TABLE OF CONTENTS Page 1. PURCHASE AND SALE OF THE WARRANT AND PREFERRED
STOCK............................................................................................................
1 1.1 Sale and Issuance of Series A-1 Preferred Stock
............................................. 1 1.2 Closing; Delivery
.............................................................................................
1 1.3 Defined Terms Used in this Agreement
........................................................... 2 2. REPRESENTATIONS
AND WARRANTIES OF THE CORPORATION.
..........................................................................................
8 2.1 Organization and Standing; Subsidiaries
......................................................... 8 2.2 Corporate Power
..............................................................................................
8 2.3 Capitalization; Governance Matters
................................................................ 9 2.4
Authorization; No Conflicts
........................................................................... 10
2.5 SEC Documents
.............................................................................................
11 2.6 Related Parties
...............................................................................................
12 2.7 Compliance with Law; Permits
...................................................................... 12 2.8
Litigation
........................................................................................................
12 2.9 Intellectual Property
.......................................................................................
13 2.10 Title to Properties and Assets;
Liens.............................................................. 14 2.11
Financial Statements; No Undisclosed Liabilities
......................................... 14 2.12 Material Adverse Effect
.................................................................................
15 2.13 Employees
......................................................................................................
15 2.14 Employee Benefit Plans
.................................................................................
16 2.15 Taxes
..............................................................................................................
17 2.16 Insurance
........................................................................................................
17 2.17 Claims
............................................................................................................
18 2.18 Negative Litigation Event
..............................................................................
18 2.19 Brokers or Finders
..........................................................................................
18 2.20 Offering
..........................................................................................................
18 2.21 Disclosure
......................................................................................................
19 3. REPRESENTATIONS AND WARRANTIES OF THE PURCHASER
...............................................................................................
19 3.1 Organization.
..................................................................................................
19 3.2 Authorization
.................................................................................................
19 3.3 Accredited Investor
........................................................................................
19 3.4 Restriction on Resale
.....................................................................................
19 3.5 Legends
..........................................................................................................
20 3.6 Brokers or Finders
..........................................................................................
20 4. COVENANTS; PURCHASER RIGHTS
................................................... 20 4.1 Information Rights
.........................................................................................
20 4.2 Board of Directors Rights
..............................................................................
22 4.3 Board Observer Rights
...................................................................................
22 4.4 Preemptive Rights
..........................................................................................
23

--------------------------------------------------------------------------------

 
[exh101agreement003.jpg]
TABLE OF CONTENTS (continued) 4.5 Reporting Status
.............................................................................................
24 4.6 Public Disclosure of Transaction
................................................................... 24 4.7
Pursuit of the Claims
......................................................................................
24 4.8 Preserve Accuracy of Representations and Warranties; Notification of
Certain Matters
...............................................................................................
24 4.9 Operations Prior to the Closing Date
............................................................. 25 4.10
Acquisition Proposals
....................................................................................
25 5. TRANSFER RESTRICTIONS
................................................................... 25 6.
CONDITIONS TO THE PURCHASER’S OBLIGATIONS AT CLOSING
.....................................................................................................
26 6.1 Representations and Warranties; Covenants
.................................................. 26 6.2 Consents, Permits and
Waivers...................................................................... 26
6.3 No Prohibitions
..............................................................................................
26 6.4 Blue Sky
.........................................................................................................
26 6.5 Certificate of Designation
..............................................................................
26 6.6 Other
..............................................................................................................
26 6.7 Schedules
.......................................................................................................
26 6.8 Closing Deliverables
......................................................................................
26 6.9 Proceedings and Documents
.......................................................................... 27 7.
CONDITIONS TO THE CORPORATION’S OBLIGATIONS AT CLOSING
.....................................................................................................
27 7.1 Representations and Warranties
..................................................................... 27 7.2 No
Prohibitions
..............................................................................................
27 7.3 Closing Deliverables
......................................................................................
27 8. TERMINATION OF THE AGREEMENT PRIOR TO CLOSING ....... 27 8.1 Termination
Triggers.
....................................................................................
27 8.2 Effect of Termination
.....................................................................................
28 9. MISCELLANEOUS
....................................................................................
28 9.1 Indemnification
..............................................................................................
28 9.2 Survival of Warranties
...................................................................................
28 9.3 Successors and Assigns
..................................................................................
29 9.4 Governing Law and Jurisdiction
.................................................................... 29 9.5
Counterparts; Facsimile or PDF
..................................................................... 29 9.6
Titles and Subtitles
.........................................................................................
29 9.7 Disclosure Schedules
.....................................................................................
29 9.8 Notices
...........................................................................................................
29 9.9 Expenses
........................................................................................................
30 9.10 Origination Fee
..............................................................................................
30 9.11 Remedies; Attorneys’ Fees
............................................................................ 30
9.12 Amendments and Waivers
............................................................................. 30
9.13 Confidentiality
...............................................................................................
30 9.14 Severability
....................................................................................................
31 9.15 Delays or Omissions
......................................................................................
31

--------------------------------------------------------------------------------

 
[exh101agreement004.jpg]
TABLE OF CONTENTS (continued) 9.16 Rights of Purchaser
........................................................................................
31 9.17 Exchange of Certificates
................................................................................
31 9.18 Entire Agreement
...........................................................................................
31 9.19 Interpretation
..................................................................................................
31 9.20 Further Assurances
.........................................................................................
32

--------------------------------------------------------------------------------

 
[exh101agreement005.jpg]
TABLE OF CONTENTS (continued) Exhibit A - FORM OF WARRANT Exhibit B - FORM OF
CERTIFICATE OF DESIGNATION

--------------------------------------------------------------------------------

 
[exh101agreement006.jpg]
SERIES A-1 PREFERRED STOCK PURCHASE AGREEMENT THIS SERIES A-1 PREFERRED STOCK
PURCHASE AGREEMENT (this “Agreement”) is made as of the 15th day of June, 2017
by and between Finjan Holdings, Inc., a Delaware corporation (the
“Corporation”), and Soryn HLDR Vehicle II LLC, a Delaware limited liability
company (the “Purchaser”). RECITALS WHEREAS, pursuant to this Agreement, the
Corporation proposes to issue to the Purchaser a common stock warrant, in
substantially the form attached hereto as Exhibit A (the “Warrant”), to purchase
2,000,000 shares of common stock, $0.0001 par value per share, of the
Corporation (the “Common Stock”) at the exercise price and upon the terms and
conditions set forth therein; WHEREAS, pursuant to this Agreement, the
Corporation proposes to issue to the Purchaser 153,000 shares of its Series A-1
Preferred Stock (the “Shares”) in exchange for a purchase price of $100 per
Share (the “Purchase Price”); and WHEREAS, the Corporation desires to issue and
sell, and the Purchaser desires to purchase, the Warrant and the Shares on the
terms and conditions set forth herein. NOW, THEREFORE, in consideration of the
foregoing recitals and the mutual promises, representations, warranties, and
covenants hereinafter set forth and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties hereto
agree as follows: 1. Purchase and Sale of the Warrant and Preferred Stock. 1.1
Sale and Issuance of Series A-1 Preferred Stock. (a) The Corporation has
authorized the issuance and sale to the Purchaser of the Shares, having the
rights and preferences set forth in the Certificate of Designation of Series A-1
Preferred Stock in the form of Exhibit B attached to this Agreement (the
“Certificate of Designation”). Immediately prior to the Closing, the Corporation
shall adopt and file the Certificate of Designation with the Secretary of State
of the State of Delaware. (b) At the Closing, subject to the terms and
conditions of this Agreement and in reliance upon the representations and
warranties of the Corporation set forth herein or in any certificate or other
document delivered pursuant hereto, the Purchaser agrees to purchase, and the
Corporation agrees to sell and issue to the Purchaser, free and clear of all
Liens, in exchange for the payment of the aggregate Purchase Price, 153,000
Shares. 1.2 Closing; Delivery. (a) The purchase and sale of the Shares (the
“Closing”) shall take place remotely via the exchange of documents and
signatures, within ten (10) Business Days of the satisfaction (or waiver by the
applicable party) of each of the conditions set forth in Section 6 and 7, or at
such other place or time or on such other date as shall be agreed to by the
Corporation and the

--------------------------------------------------------------------------------

 
[exh101agreement007.jpg]
2 Purchaser. The time and date on which the Closing is actually held are
sometimes referred to herein as the “Closing Date.” (b) At the Closing, subject
to satisfaction or waiver of the conditions set forth in Section 7, the
Corporation shall (i) issue and deliver to the Purchaser, free and clear of all
Liens, a stock certificate, duly executed by the Corporation and registered in
the Corporation’s stock ledger in the Purchaser’s or its nominee’s name,
evidencing the number of Shares to be purchased by such Purchaser as set forth
in Section 1.1(b) and (ii) deliver to the Purchaser the Warrant to purchase
2,000,000 shares of Common Stock at the exercise price and upon the terms and
conditions as set forth therein. (c) Subject to satisfaction or waiver of the
conditions set forth in Section 6 at Closing, as payment in full for the Shares
being purchased by it under this Agreement, and against delivery of the stock
certificate(s) therefor as described in subparagraph (b) above and the Warrant,
at the Closing, the Purchaser shall pay the aggregate Purchase Price of
$15,300,000 (less the Purchaser Expenses and Origination Fee as set forth in
Sections 9.9 and 9.10, respectively) for the Purchaser’s Shares by wire transfer
of immediately available funds, to the Corporation’s operating bank account (the
“Treasury Account”) designated by the Corporation at least two (2) Business Days
prior to Closing. (d) The Corporation has authorized and has initially reserved
and covenants to continue to reserve, free of preemptive rights and other
similar contractual rights of stockholders, a number of its authorized but
unissued shares of Common Stock at least equal to the aggregate number of shares
of Common Stock to effect the exercise of the Warrant in full. Any shares of
Common Stock issuable upon exercise of the Warrant (and such shares when issued)
are herein referred to as the “Warrant Shares”. The Warrant, the Warrant Shares
and the Shares are sometimes collectively referred to herein as the
“Securities”. 1.3 Defined Terms Used in this Agreement. In addition to the terms
defined above and throughout this Agreement, the following terms used in this
Agreement shall be construed to have the meanings set forth or referenced below.
“Adverse Party” means the Defendants and their respective Affiliates as well as
any other party (i) subsequently named as a defendant in any Proceedings
(including any litigation or arbitration or any collection actions arising
therefrom or connected to the Claims), (ii) who enters into an arrangement or
agreement that grants license or sublicense rights to any party that qualifies
as an Adverse Party pursuant clause (i) above, or (iii) with whom the
Corporation, any Corporation Subsidiary or any of their respective successor(s)
in interest or assigns or Affiliates institutes or has instituted legal action
against, whether in the United States or internationally, on or before the date
hereof. “Affiliate” means, with respect to any specified Person, any other
Person who, directly or indirectly, controls, is controlled by, or is under
common control with such Person, including any general partner, managing member,
officer or director of such Person or any venture capital fund now or hereafter
existing that is controlled by one or more general partners or managing members
of, or shares the same management company with, such Person.

--------------------------------------------------------------------------------

 
[exh101agreement008.jpg]
3 “Amended and Restated Certificate” means the Amended and Restated Certificate
of Incorporation of the Corporation dated July 10, 2014. “Business Day” means a
day banks in New York City are open for regular business. “Bylaws” means the
Amended and Restated Bylaws of the Corporation effective as of July 10, 2014.
“Claims” means any and all claims, causes of action, rights, choses in action,
and entitlements, known or unknown, existing or later arising, in connection
with the Litigation, the Proceedings or the Patents, in favor of the
Corporation, any Corporation Subsidiary and/or their respective Affiliates,
against any Adverse Party, including the Litigation and any claims, causes of
action, rights, choses in action, and entitlements, known or unknown, existing
or later arising, in connection therewith. “Code” means the Internal Revenue
Code of 1986. “Confidential Information” means any information relating to the
Corporation or any Corporation Subsidiary provided to Purchaser or any Affiliate
of Purchaser (or any advisor thereof), under or in connection with any
Transaction Documents, including any information provided orally and any
document, file or any other way of representing or recording information which
contains or is derived from such information other than: (a) information that is
or becomes public knowledge other than as a result of a breach of Section 8.12
(Confidentiality) by Purchaser or any Affiliate of Purchaser (or any advisor
thereof); (b) information previously known by or in the possession of Purchaser
or any Affiliate of Purchaser (or any advisor thereof); or (c) information
lawfully obtained by Purchaser or any Affiliate of Purchaser (or any advisor
thereof) from a third party not reasonably known to Purchaser to be bound by a
duty of confidentiality to the Corporation. “Contract” means all contracts,
agreements, commitments, understandings and arrangements, whether written or
oral. “Corporation” has the meaning set forth in the introductory paragraph.
“Defendants” means, collectively, (i) FireEye, Inc., (ii) Blue Coat Systems,
Inc., (iii) Symantec Corporation, (iv) Palo Alto Networks, Inc., (v) ESET, LLC
et al, (vii) Cisco Systems, Inc. and (vi) any other party with whom the
Corporation, any Corporation Subsidiary or any of their respective successor(s)
in interest or assigns or Affiliates institutes or has instituted legal action
against with respect to patent, trademark or copyright infringement or trade
secret matters, whether on before or after the date hereof. “Exchange Act” means
the Securities Exchange Act of 1934. “Fiscal Year” means for financial
accounting purposes, January 1 to December 31. “GAAP” means generally accepted
accounting principles as applied in the United States.

--------------------------------------------------------------------------------

 
[exh101agreement009.jpg]
4 “Governmental Entity” means any court or tribunal or administrative,
governmental or regulatory body or agency (whether foreign, federal, state,
local or other). “Indebtedness” means, with respect to any Person, all
indebtedness of such Person for borrowed money, including (i) all indebtedness
evidenced by notes, debentures, bonds or similar instruments; (ii) all capital
lease obligations; (iii) all obligations issued or assumed as the deferred
purchase price of property or services (other than trade payables incurred in
the ordinary course of business); (iv) all obligations (whether fixed or
contingent) to reimburse any bank or other Person in respect of amounts paid or
payable under a standby letter of credit; (v) all guarantees of obligations of
the type described in clauses (i) through (iv) of this definition of another
Person; and (vi) all obligations under any acquisition agreements pursuant to
which such Person is responsible for any earn out, note payable or other
contingent payments. “Intellectual Property Rights” means all (i) inventions
(whether or not patentable), patent disclosures, patents, patent applications,
and all divisions, continuations and continuations– in–part, and any renewals,
extensions, reexaminations and reissues thereof, (ii) trademarks, service marks,
trade dress, trade names, URL’s, logos and corporate names and registrations and
applications for registration thereof, together with all of the goodwill
associated therewith, (iii) copyrights (registered or unregistered) and
copyrightable works and registrations and applications for registration thereof,
(iv) mask works and registrations and applications for registration thereof, (v)
computer software, data, data bases and documentation thereof, (vi) trade
secrets and other confidential information (including ideas, formulas,
compositions, inventions (whether patentable or unpatentable and whether or not
reduced to practice), know-how, manufacturing and production processes and
techniques, research and development information, drawings, specifications,
designs, plans, proposals, technical data, copyrightable works, financial and
marketing plans and customer and supplier lists and information), (vii) other
intellectual property rights and (viii) copies and tangible embodiments thereof
(in whatever form or medium). “Knowledge” including the phrase “to the
Corporation’s knowledge,” shall mean the knowledge after reasonable inquiry of
each of the officers of the Corporation or any Corporation Subsidiary. “Liens”
means any mortgage, pledge, security interest, encumbrance, lien, claim or
charge of any kind (including any conditional sale or other title retention
agreement or lease in the nature thereof), any sale of receivables with recourse
against the Corporation, any Corporation Subsidiary or any of their respective
Affiliates, any filing or agreement to file a financing statement as debtor
under the Uniform Commercial Code or any similar statute other than to reflect
ownership by a third party of property leased to the Corporation under a lease
that is not in the nature of a conditional sale or title retention agreement, or
any subordination arrangement in favor of another Person (other than any
subordination arising in the ordinary course of business). “Litigation” means,
collectively, those Claims set forth on Annex A. “Material Adverse Effect” means
any material and adverse effect on the assets, liabilities, condition, business,
results of operations, prospects, management or affairs of the Corporation and
the Corporation Subsidiaries, taken as a whole.

--------------------------------------------------------------------------------

 
[exh101agreement010.jpg]
5 “Minimum Treasury Amount” means $6,000,000. “NASDAQ” means The NASDAQ Capital
Market. “Negative Litigation Event” means the occurrence of any of the
following: (a) any subsequent decision (after the Date of Issuance) by the
United States Court of Appeals for the Federal Circuit or the District Court for
the Northern District of California that has the effect of setting the damages
amount owed to the Corporation or the Corporation Subsidiaries by Blue Coat
Systems Inc. in Case No. 5:13-cv-03999-BLF (N.D. Cal) at fifty percent (50%) or
less of the damages awarded on August 4, 2015 (the “Awarded Damages”), or (b)
the decision of any Governmental Entity materially affecting the ability of the
Corporation or the Corporation Subsidiaries to collect more than fifty percent
(50%) of the Awarded Damages from Blue Coat Systems, Inc., as reasonably
determined in good faith by holders of more than fifty percent (50%) of the
Shares or (c) Symantec Corporation (or any successor thereto) experiences a
bankruptcy, liquidation, receivership or assignment for benefit of creditors.
“Negative Treasury Event” means any consecutive 60 day period of time during
which the balance of cash and cash equivalents in the Treasury Account
(excluding amounts applicable to the Aggregate Exercise Price (as defined in the
Warrant)) is less than the Minimum Treasury Amount. “New Securities” means any
equity securities of the Corporation or any Corporation Subsidiary issued after
the date hereof, whether or not now authorized, and rights, options or warrants
to purchase such equity securities of any type whatsoever that are, or may by
their terms become, convertible into or exchangeable for such equity securities;
provided that, notwithstanding the foregoing, “New Securities” shall not include
the following: (i) equity securities of the Corporation or any Corporation
Subsidiary or other securities issued on a pro rata basis as a dividend or
distribution on, or in connection with a split of or recapitalization of, any of
equity securities of the Corporation or any Corporation Subsidiary; (ii) shares
of Common Stock issued pursuant to awards issued under the Corporation’s equity
incentive plans to employees, directors or consultants of the Corporation or any
Corporation Subsidiary; (iii) shares of any Corporation Subsidiary in which
following such issuance, such Corporation Subsidiary is directly or indirectly a
wholly-owned subsidiary of the Corporation; (iv) equity securities of the
Corporation issued in an offering for cash for the account of the Company which
offering is registered with the Securities and Exchange Commission under the
Securities Act; (v) shares of Common Stock issued or issuable pursuant to the
acquisition of another unrelated entity by the Corporation by merger, purchase
of substantially all of the assets or other reorganization or to Persons in
connection with a joint venture agreement or strategic alliance with such
Person, provided, that such issuances are approved by the Corporation’s Board of
Directors; (vi) shares of Common Stock issued or issuable in connection with any
settlement of any action, suit, proceeding or litigation approved by the
Corporation’s Board of Directors; (vii) shares of Common Stock issued or
issuable in or under a transaction for which the holders of at least a majority
of the then outstanding Shares consent or approve as not being considered New
Securities; and (viii) the Warrant and the Warrant Shares. “Patents” means,
collectively, the patents set forth on Annex B as revised from time to time.

--------------------------------------------------------------------------------

 
[exh101agreement011.jpg]
6 “Person” means any individual, corporation, partnership, trust, limited
liability company, association or other entity. “Proceedings” means (i) the
Claims (and other proceedings relating thereto, including dispute resolution
proceedings), (ii) any and all related pre- and post-trial proceedings or
processes in or in connection with the Claims; (iii) all appellate proceedings
and proceedings on remand, as well as enforcement, ancillary, parallel or
alternate dispute resolution proceedings and processes arising out of or related
to the acts or occurrences alleged in the Claims; (iv) re-filings or parallel
filings relating to the Claims and any other legal, diplomatic or administrative
proceedings or processes founded on the underlying facts giving rise to or
forming a basis for the Claims, in which the Corporation, any Corporation
Subsidiary or any of their respective successor(s) in interest or assigns or
Affiliates is a party; (v) ancillary or enforcement proceedings related to the
facts or Claims alleged from time to time; and (vi) all arrangements,
settlements, negotiations, or compromises made between the Corporation or any
Corporation Subsidiary or any of their respective Affiliates or representatives
and any Adverse Party having the effect of resolving any of the Claims against
any Adverse Party. “Proceeds” means (A) any and all pre-Tax monetary award,
damages, fees, recoveries, judgments or other property or value recovered by or
on behalf of the Corporation or any Corporation Subsidiary or their respective
Affiliates on account or as a result or by virtue (directly or indirectly) of
the Claims or the Proceedings, whether by negotiation, litigation, arbitration,
mediation, diplomatic efforts, lawsuit, settlement, decree, judgment or
otherwise and whether against the Defendants or any other Adverse Party
(including any Person unrelated to the Defendants who may infringe on the
Patents), and includes all of the Corporation’s and each Corporation
Subsidiary’s legal and/or equitable rights, title and interest in and/or to any
of the foregoing, whether in the nature of ownership, lien, security interest or
otherwise, plus (B) any actually and successfully recovered interest, penalties,
lawyer’s fees and costs in connection with any of the foregoing, plus (C) any
consequential, actual, moral, punitive, exemplary, special, incidental, lost
profits or treble damages awarded and actually and successfully recovered on
account thereof, plus (D) any interest actually and successfully awarded or
later accruing on any of the foregoing, plus (E) any recoveries from actions
commenced by the Corporation or any Corporation Subsidiary against lawyers,
accountants, experts or officers in connection with any of the foregoing or the
pursuit of the Proceedings. For the avoidance of doubt, “Proceeds” includes
cash, real estate, negotiable instruments, choses in action, contract rights,
membership rights, subrogation rights, annuities, future revenue streams
(including milestone and royalty payments), claims, refunds, and any other
rights to payment of cash and/or transfer(s) of things of value or other
property (including property substituted therefor), whether delivered or to be
delivered in a lump sum or in installments, in relation to any claim or
negotiation with any Person in relation to the Proceedings, and shall include
any award of rescissionary, punitive, consequential, treble or exemplary damages
or penalties assessed against any Adverse Party from time to time. “Requirements
of Laws” means any applicable United States federal, state and local, and any
non-U.S., laws, statutes, regulations, rules, codes or ordinances enacted,
adopted, issued or promulgated by any Governmental Entity, including, if and to
the extent the Corporation is subject thereto, any applicable listing
requirements and rules and regulations of NASDAQ and any other stock exchange or
interdealer quotation system.

--------------------------------------------------------------------------------

 
[exh101agreement012.jpg]
7 “Restricted Securities” means (i) the Shares issued hereunder, (ii) any
securities issued with respect to the Shares by way of a stock dividend or stock
split or in connection with a combination of shares, recapitalization, merger,
consolidation or other reincorporation (iii) the Warrant, and (iv) the Warrant
Shares. As to any particular Restricted Securities, such securities shall cease
to be Restricted Securities when they have (a) been effectively registered under
the Securities Act and disposed of in accordance with the registration statement
covering them, (b) been distributed to the public through a broker, dealer or
market maker pursuant to Rule 144 (or any similar provision then in force) under
the Securities Act or become eligible for sale pursuant to Rule 144(b) (or any
similar provision then in force) under the Securities Act, or (c) been otherwise
transferred and new certificates for them not bearing the Securities Act legend
set forth in Section 5.1 have been delivered by the Corporation. Whenever any
particular securities cease to be Restricted Securities, the holder thereof
shall be entitled to receive from the Corporation, without expense, new
securities of like tenor not bearing a Securities Act legend of the character
set forth in Section 5.1. “SEC” means the Securities and Exchange Commission,
including any Governmental Entity or agency succeeding to the functions thereof.
“Securities Act” means the Securities Act of 1933. “Side Letter” means that
certain letter agreement between the Corporation and the Purchaser dated as of
the date of this Agreement. “Subsidiary” means, with respect to any Person, any
other Person of which a majority of the outstanding shares or other equity
interests having the power to vote for directors or comparable managers are
owned, directly or indirectly, by the first Person. “Tax Return” means any
return, report or similar statement required to be filed with respect to any Tax
(including any attached schedules), including any information return, claim for
refund, amended return or declaration of estimated Tax. “Taxes” means any
federal, foreign, state, county and local income, gross receipts, excise,
import, property, franchise, ad valorem, license, sales or use tax or other
withholding, social security, Medicare, unemployment compensation or other
employment-related tax, or any other charge, together with all deficiencies,
penalties, additions, interest, assessments, and other governmental charges with
respect thereto. “Transaction Documents” means this Agreement, the Common
Interest Agreement, the Certificate of Designation, the Side Letter, the Warrant
and any other agreements, instruments or documents entered into in connection
with this Agreement. Each of the following terms is defined in the Section set
forth opposite such term: Balance Sheet Section 2.3(h) Board of Directors
Section 2.12 Certificate of Designation Section 1.1(a) Closing Section 1.2(a)
Closing Date Section 1.2(a)

--------------------------------------------------------------------------------

 
[exh101agreement013.jpg]
8 Common Stock Section 2.3 Corporation Introductory paragraph Corporation
Subsidiary Section 2.1(b) Disclosure Schedules Section 2 ERISA Section 2.13
Exercise Period Section 4.4(b) Indemnified Party/Parties Section 9.1(a) Losses
Section 9.1(a) Nominee Section 4.2(a) Observer Section 4.3 Preemptive Right
Notice Section 4.4(b) Preferred Stock Section 2.3(a) Purchase Expenses Section
9.9 Purchase Price Recitals Purchaser Introductory paragraph SEC Documents
Section 2.5 Shares Recitals 2. Representations and Warranties of the
Corporation. As an inducement to the Purchaser to enter into this Agreement and
to purchase the Securities, except as set forth in the Disclosure Schedules
attached hereto (the “Disclosure Schedules”) specifically identifying the
subsection of this Section 2 to which such exception relates, the Corporation
hereby represents and warrants to the Purchaser, as follows: 2.1 Organization
and Standing; Subsidiaries. (a) The Corporation is a corporation duly organized,
validly existing and in good standing under the laws of the State of Delaware
and has all requisite corporate power and authority to carry on its business as
presently conducted and as proposed to be conducted. The Corporation is duly
qualified or licensed to transact business as a foreign corporation and is in
good standing in each of the jurisdictions listed in Schedule 2.1(a), which
jurisdictions are the only ones in which the ownership or leasing of its assets
or the conduct of its business requires such qualification or licensing. No
other jurisdiction has demanded, requested or otherwise indicated that the
Corporation is required to so qualify. (b) Each of the Subsidiaries of the
Corporation is set forth on Schedule 2.1(b) (collectively, the “Corporation
Subsidiaries”). Each Corporation Subsidiary is a corporation duly organized,
validly existing and in good standing under the laws of its jurisdiction of
incorporation or formation and has all requisite power and authority to carry on
its business as presently conducted and as proposed to be conducted. Each of the
Corporation Subsidiaries is duly qualified or authorized to conduct business and
is in good standing under the laws of each jurisdiction where such qualification
or authorization is required. 2.2 Corporate Power. The Corporation has all
requisite power and authority to execute and deliver this Agreement and each of
the other Transaction Documents, to issue, sell and

--------------------------------------------------------------------------------

 
[exh101agreement014.jpg]
9 deliver the Securities, and to carry out and perform its obligations under the
terms of this Agreement and each of the other Transaction Documents. 2.3
Capitalization; Governance Matters. (a) The authorized capital stock of the
Corporation consists, immediately prior to the Closing, of: (i) 80,000,000
shares of common stock, $0.0001 par value per share (the “Common Stock”), the
number of shares of which (A) are issued and outstanding or (B) reserved for
issuance to employees, consultants and directors pursuant to the Finjan
Holdings, Inc. 2013 Global Share Option Plan, the Finjan Holdings, Inc. 2014
Incentive Compensation Plan, and the Finjan Holdings, Inc. Israeli Appendix to
the 2014 Incentive Compensation Plan upon the exercise of outstanding stock
options or other awards held by Corporation employees thereunder, are as set
forth on Schedule 2.3; (ii) 10,000,000 shares of Preferred Stock, $0.0001 par
value per share (the “Preferred Stock”), of which (A) 102,000 have been
designated Series A Preferred Stock, and none of which are issued and
outstanding, and (B) 153,000 have been designated Series A-1 Preferred Stock,
and none of which are issued and outstanding. (b) All issued and outstanding
shares of Common Stock (i) have been duly authorized, (ii) were validly issued
in compliance with Requirements of Law, including all federal and state
securities laws, (iii) are fully paid and nonassessable, and (iv) were not
issued in violation of any preemptive or similar rights. (c) The Amended and
Restated Certificate (which, as of the Closing, shall be as supplemented by the
Certificate of Designation) is in full force and effect. The designations,
powers, preferences, rights, qualifications, limitations and restrictions in
respect of each class and series of authorized capital stock of the Corporation,
including the Shares, are as set forth in the Amended and Restated Certificate
(which, as of the Closing, shall be as supplemented by the Certificate of
Designation) and all such designations, powers, preferences, rights,
qualifications, limitations and restrictions are valid, binding and enforceable
(except as such enforceability may be limited by bankruptcy, insolvency,
reorganization, moratorium or similar laws affecting creditors’ rights generally
and by general equitable principles) and in accordance with all Requirements of
Law. The Shares and the Warrant Shares, when issued and delivered and paid for
in compliance with the provisions of this Agreement and the Amended and Restated
Certificate (which, as of the Closing, shall be as supplemented by the
Certificate of Designation), will be validly issued, fully paid and
non-assessable. When issued, sold and delivered in accordance with the terms of
this Agreement, the Shares and the Warrant Shares will be (i) free of any Liens,
other than any Liens created by or through the Purchaser and restrictions on
transfer under U.S. state and/or federal securities laws and as set forth
herein, and (ii) issued in compliance with all Requirements of Law including
state and federal securities laws. (d) No Person is entitled to any pre-emptive
right or right of first refusal with respect to the issuance of any capital
stock of the Corporation, including the Shares and the

--------------------------------------------------------------------------------

 
[exh101agreement015.jpg]
10 Warrant Shares. The issuance of the Shares and the Warrant Shares will not
trigger any anti-dilution provisions of any outstanding securities of the
Corporation. Other than as set forth on Schedule 2.3(d) or as contemplated by
this Agreement, there are no options, warrants or other rights (including
conversion or preemptive rights and rights of first refusal) to purchase any of
the Corporation’s authorized and unissued capital stock or any securities
convertible or exchangeable into any of the Corporation’s capital stock. There
are no outstanding stock appreciation, phantom stock, profit participation, or
similar rights with respect to the Corporation. To the Corporation’s Knowledge,
there are no voting trusts, proxies, or other agreements or understandings with
respect to the voting of any equity securities of the Corporation, except in
connection with proxies in connection with the Corporation’s 2016 Annual Meeting
of Stockholders. (e) Except as provided by this Agreement or as set forth in
Schedule 2.3(e), the Corporation is not a party to any agreement with the holder
of any of its securities that requires the Corporation to purchase any of such
securities from their holder under any circumstances. (f) The Corporation has no
Indebtedness other than as set forth in Schedule 2.3(f). (g) Except for the
Corporation Subsidiaries, the Corporation does not own any capital stock,
membership interests, security or other interest in any other Person. Except as
set forth in Schedule 2.3(g), neither the Corporation nor any of the Corporation
Subsidiaries has any understanding or agreement to provide funds to, or make any
investment (in the form of a loan, capital contribution or otherwise) in, any
other Person. All of the issued and outstanding equity securities of each of the
Corporation Subsidiaries have been duly authorized and are validly issued. The
Corporation holds of record and owns beneficially 100% of the outstanding equity
securities of each Corporation Subsidiary free and clear of any Liens, options,
warrants, purchase rights, contracts, commitments, equities, claims and demands.
Except as set forth on Schedule 2.3(g), there are no outstanding or authorized
options, warrants, purchase rights, subscription rights, conversion rights,
exchange rights, or other contracts or commitments that could require the
Corporation or any of the Corporation Subsidiaries to sell, transfer, or
otherwise dispose of any equity securities of any of the Corporation
Subsidiaries or that could require any Corporation Subsidiary to issue, sell, or
otherwise cause to become outstanding any of its own equity securities. There
are no outstanding stock appreciation, phantom stock, profit participation, or
similar rights with respect to any Corporation Subsidiary. There are no voting
trusts, proxies, or other agreements or understandings with respect to the
voting of any equity securities of any Corporation Subsidiary. (h) Effective as
of immediately before the Closing, the number of directors of the Corporation’s
Board of Directors (the “Board of Directors”) is seven (7) persons, although
eight (8) persons have been authorized. 2.4 Authorization; No Conflicts. (a) All
corporate action on the part of the Corporation, its officers, directors and
stockholders necessary for the authorization, execution, delivery and
performance by the Corporation of this Agreement and the other Transaction
Documents and all obligations and

--------------------------------------------------------------------------------

 
[exh101agreement016.jpg]
11 transactions contemplated hereby and thereby, the filing of the Certificate
of Designation and the authorization, sale, issuance and delivery of the Shares
and the Warrant, has been taken. When the Warrant Shares are issued and paid for
in accordance with the terms of this Agreement and as set forth in the Warrant,
such Warrant Shares will be duly authorized by all corporate action necessary
for the authorization, sale, issuance and delivery of the Warrant Shares. This
Agreement and the other Transaction Documents, when executed and delivered by
the Corporation, shall constitute valid and binding obligations of the
Corporation, enforceable against the Corporation in accordance with their terms
except as such enforceability may be limited by bankruptcy, insolvency,
reorganization, moratorium or similar laws affecting creditors’ rights generally
and by general equitable principles. The Corporation (a) is not required to
obtain the approval of the owners or holders of its Common Stock in order to
authorize and consummate the transactions contemplated by this Agreement or any
of the other Transaction Documents and (b) has obtained the approvals of all
Persons necessary to authorize and consummate the transactions contemplated by
this Agreement and the other Transaction Documents. (b) Neither the execution
and delivery of this Agreement or any of the other Transaction Documents or the
consummation of any of the transactions contemplated hereby or thereby nor
compliance with or fulfillment of the terms, conditions and provisions hereof or
thereof will: (i) conflict with, result in a breach or violation of the terms,
conditions or provisions of, or constitute a default, an event of default or an
event creating rights of acceleration, termination or cancellation or a loss of
rights under, or result in the creation or imposition of any Lien upon any of
the assets or properties of the Corporation or any Corporation Subsidiary, under
(A) the Amended and Restated Certificate or the Bylaws, (B) any note,
instrument, contract, agreement, mortgage, lease, license, franchise, permit or
other authorization, right, restriction or obligation to which the Corporation
or any Corporation Subsidiary is a party or any of its assets or properties is
subject or by which the Corporation or any Corporation Subsidiary is bound, (C)
any order, injunction, temporary restraining order, judgment, award, decree or
ruling of any Governmental Entity to which the Corporation or any Corporation
Subsidiary is a party or any of its assets or properties is subject or by which
the Corporation or any Corporation Subsidiary is bound, (D) any rule or
regulation of NASDAQ or other Requirements of Law; or (ii) require the approval,
consent, authorization or act of, or the making by the Corporation or any
Corporation Subsidiary of any declaration, filing or registration with, any
Person (except for, with respect to the offer and sale of the Securities, (a)
any required filings under state securities laws and (b) routine post-Closing
notice filings with the SEC and under state corporation and securities laws,
each of which have been or will be filed timely within the applicable period
therefor). 2.5 SEC Documents. The Common Stock is registered pursuant to Section
12(g) of the Exchange Act and the Corporation has filed all reports, schedules,
forms, statements and other documents required to be filed by it with the SEC
pursuant to the reporting requirements of the Exchange Act, including all such
annual, quarterly and current reports, proxy information, solicitation statement
and registration statements, and amendments thereto required to have been

--------------------------------------------------------------------------------

 
[exh101agreement017.jpg]
12 filed (all of the foregoing and all exhibits included therein and financial
statements and schedules thereto and documents incorporated by reference therein
being referred to herein as the “SEC Documents”). As of the date of filing of
such SEC Documents, the SEC Documents complied in all material respects with the
applicable requirements of the regulations of the Exchange Act and the rules and
regulations promulgated thereunder and other Federal, state and local laws,
rules and regulations applicable to such SEC Documents. None of the SEC
Documents contained any untrue statement of a material fact or omitted to state
a material fact required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which they were made,
not misleading. The SEC Documents contain all material information concerning
the Corporation, and no event or circumstance has occurred prior to the date
hereof that would require the Corporation to disclose such event or circumstance
in order to make the statements in the SEC Documents not misleading but which
has not been so disclosed. The Corporation is not required to file and will not
be required to file any Contract entered into prior to the date hereof and to
which the Corporation is a party or by which the Corporation is bound that has
not been previously filed as an exhibit to its reports filed with the SEC under
the Exchange Act. 2.6 Related Parties. (a) Except as disclosed in Schedule
2.6(a), none of the officers, directors, or to the Corporation’s Knowledge, any
key employee of the Corporation or any Corporation Subsidiary or any members of
their immediate families or other Affiliates, has any direct or indirect
ownership interest in any firm or corporation with which the Corporation or any
Corporation Subsidiary is affiliated or with which the Corporation or any
Corporation Subsidiary has a business relationship, or any firm or corporation
which competes with the Corporation, other than passive investments in publicly
traded companies (representing less than 1% of such company). No employee,
officer, director or other Affiliate of the Corporation or member of his or her
immediate family is indebted to the Corporation, nor is the Corporation indebted
(or committed to make loans or extend or guarantee credit) to any of them. (b)
To the Knowledge of the Corporation, except for (i) this Agreement and the other
Transaction Documents and (ii) the agreements set forth on Schedule 2.6(b),
there are no other agreements, understandings or proposed transactions between
the Corporation and any of its officers, directors, or holders of the
Corporation’s outstanding capital stock or any Affiliate thereof, including
spouses, or family members of any such officer, director or holders of such
stock, or that would otherwise be required to be disclosed pursuant to Item 404
of Regulation S-K of the SEC. 2.7 Compliance with Law; Permits. The Corporation
and each of the Corporation Subsidiaries is in compliance with all material
Requirements of Law. The Corporation and the Corporation Subsidiaries have all
material franchises, permits, licenses and any similar authority necessary for
the conduct of their respective businesses as now being conducted by them and
believe they can obtain, without undue burden or expense, any similar authority
for the conduct of their respective business as planned to be conducted. Neither
the Corporation nor any Corporation Subsidiary is in default in any material
respect under any such franchises, permits, licenses or similar authority.

--------------------------------------------------------------------------------

 
[exh101agreement018.jpg]
13 2.8 Litigation. Except for the patent challenges disclosed in the SEC
Documents, there are no actions, suits, proceedings, arbitrations, charges,
complaints or investigations pending against the Corporation or any Corporation
Subsidiaries or their respective properties nor, to the Knowledge of the
Corporation, is there any basis for any of the foregoing (nor has the
Corporation or any Corporation Subsidiary received notice of any threat
thereof). The foregoing includes any actions, suits, proceedings, arbitrations,
charges, complaints or investigations that questions the validity of this
Agreement or the other Transaction Documents or the right of the Corporation to
enter into any of such agreements, or to consummate the transactions
contemplated hereby or thereby, or which could reasonably be expected to result,
either individually or in the aggregate, in any material adverse effect upon the
Corporation or any Corporation Subsidiary or any change in the current equity
ownership of the Corporation or any Corporation Subsidiary. Neither the
Corporation nor any Corporation Subsidiary is a party or subject to the
provisions of any order, writ, injunction, judgment or decree of any court or
Governmental Entity or instrumentality. Except for (i) the Litigation or (ii) as
set forth on Schedule 2.8, there is no action, suit, proceeding, arbitration,
charge, complaint or investigation by the Corporation or any Corporation
Subsidiary currently pending or which the Corporation or any Corporation
Subsidiary intends to initiate. 2.9 Intellectual Property. (a) Schedule 2.9(a)
contains a complete and accurate list of all (i) patented, issued or registered
Intellectual Property Rights owned or used by the Corporation or any Corporation
Subsidiaries, in each case identifying the patent or registration number, the
applicable jurisdiction, the owner, and the registration date, (ii) pending
patent applications and applications for registrations of other Intellectual
Property Rights filed by the Corporation or any Corporation Subsidiaries, in
each case identifying the application number, the applicable jurisdiction, the
owner, and the filing date, (iii) unregistered trade names and corporate names
owned or used by the Corporation or any Corporation Subsidiaries, and (iv)
unregistered trademarks and service marks owned or used by the Corporation or
any Corporation Subsidiaries. Schedule 2.9(a) also contains a complete and
accurate list of all licenses granted by the Corporation or any Corporation
Subsidiaries to any third party with respect to any Intellectual Property Rights
and all licenses and other rights granted by any third party to the Corporation
or any Corporation Subsidiaries with respect to any Intellectual Property
Rights, in each case identifying the subject Intellectual Property Rights. The
Corporation or the Corporation Subsidiaries owns all right, title and interest
to, or has the right to use pursuant to a valid license, all Intellectual
Property Rights necessary for the operation of the business of the Corporation
and each of the Corporation Subsidiaries as presently conducted and as presently
proposed to be conducted, free and clear of all Liens. The Intellectual Property
Rights set forth on Schedule 2.9(a) are subsisting, valid and enforceable and no
such items are subject to any outstanding injunction, judgment, order, decree,
ruling or charge. The loss or expiration of any Intellectual Property Right or
related group of Intellectual Property Rights owned or used by the Corporation
or any Corporation Subsidiaries has not had a material adverse effect, and no
such loss or expiration is threatened, pending or reasonably foreseeable. The
Corporation and the Corporation Subsidiaries have taken reasonable actions to
maintain and protect the Intellectual Property Rights that any such entity owns
and uses, including causing its employees or contractors to execute invention
assignment, non-disclosure and confidentiality agreements. In each case where an
item of issued, registered, or pending Intellectual Property Rights is owned by
the Corporation or any Corporation Subsidiary (i) the Corporation and the
Corporation Subsidiaries are currently in

--------------------------------------------------------------------------------

 
[exh101agreement019.jpg]
14 compliance with all legal requirements and the Corporation or the applicable
Corporation Subsidiary has paid all filing, registration, maintenance and
renewal fees for any issued, registered or pending Intellectual Property Rights
with the relevant patent, copyright, or trademark office including the U.S.
Patent and Trademark Office, and (ii) there are no defects in the filing or
prosecution of such items. In each case where an item of issued, registered, or
pending Intellectual Property Rights is owned by the Corporation or the
Corporation Subsidiaries by assignment, the assignment has been duly recorded
with the proper patent, copyright, or trademark office including the U.S. Patent
and Trademark Office. (b) Except as indicated on Schedule 2.9(b), (i) there have
been no claims or demands of any kind pertaining to, or any proceeding
(including any court, or administrative proceeding at the U.S. Patent and
Trademark Office) which is pending or threatened against the Corporation or any
Corporation Subsidiary asserting or alleging the invalidity, misuse or
unenforceability of any of such Intellectual Property Rights listed on Schedule
2.9(a), and to the Corporation’s Knowledge, there are no grounds for the same,
(ii) neither the Corporation nor any Corporation Subsidiaries has received any
written notices of, and neither the Corporation nor any Corporation Subsidiaries
is aware of any facts that indicate a reasonable likelihood of, any infringement
or misappropriation by, or conflict with, any third party with respect to such
Intellectual Property Rights (including any demand or request that the
Corporation or any Corporation Subsidiaries license any rights from a third
party or indemnify any third party), (iii) to the Corporation’s Knowledge, the
conduct of the Corporation’s or any Corporation Subsidiaries’ business has not
infringed, misappropriated or conflicted with and does not infringe,
misappropriate or conflict with any Intellectual Property Rights of third
parties, and (iv) to the knowledge of the Corporation, except as indicated on
Schedule 2.9(b)(iv), the Intellectual Property Rights owned by or licensed to
the Corporation or any Corporation Subsidiaries have not been infringed,
misappropriated or violated by third parties. 2.10 Title to Properties and
Assets; Liens. The Corporation has good and marketable title to, or good and
valid leasehold interests in, its properties and assets, tangible and
intangible, in each case free and clear of any Liens, other than (i) for liens
for current taxes not yet due and payable, (ii) for liens imposed by law and
incurred in the ordinary course of business for obligations not past due and
which are not material, (iii) for liens in respect of pledges or deposits under
workers’ compensation laws or similar legislation, and (iv) minor liens,
encumbrances and defects in title which do not in any case materially detract
from the value of the property subject thereto or materially impair the
operations of the Corporation, and which have not arisen otherwise than in the
ordinary course of business. 2.11 Financial Statements; No Undisclosed
Liabilities. (a) The financial statements (including, in each case, any related
notes) of the Corporation included in the SEC Documents are complete and
accurate in all material respects and complied as to form and substance in all
material respects with applicable accounting requirements of the SEC and the
published rules and regulations of the SEC or other applicable national
securities exchange or inter-dealer quotation system rules or regulations with
respect thereto. Such financial statements were prepared in accordance with
GAAP, applied consistently, during the periods involved (except in the case of
unaudited interim statements, to the extent that they may

--------------------------------------------------------------------------------

 
[exh101agreement020.jpg]
15 include footnotes, may be condensed or summary statements) and fairly
presented in all material respects, the financial position of the Corporation
and the Corporation Subsidiaries as of the respective dates thereof and the
results of operations and cash flows for the periods indicated. (b) Except (i)
to the extent shown or reserved for in the Balance Sheet, (ii) liabilities
and/or obligations incurred after the date of the Balance Sheet in the ordinary
course of business or (iii) obligations to perform under contracts which are not
required under GAAP to be reflected in the financial statements of the
Corporation, the Corporation has not and is not subject to any liabilities or
obligations of any nature (including unasserted claims, whether known or
unknown), whether or not accrued, contingent or otherwise. 2.12 Material Adverse
Effect. Since the date of the balance sheet included in the most recently filed
SEC Documents (the “Balance Sheet”), no event has occurred that has had or would
be reasonably likely to have a Material Adverse Effect. 2.13 Employees. Except
as disclosed on Schedule 2.13, to the Corporation’s Knowledge, no employee or
officer of, nor any consultant to, the Corporation or any Corporation Subsidiary
is in violation of any term of any employment or consulting contract, patent
disclosure agreement or any other contract or agreement relating to the
relationship of such employee or consultant with the Corporation or any
Corporation Subsidiary or any other party because of the nature of the business
conducted or proposed to be conducted by the Corporation or any Corporation
Subsidiary. Each employee and officer of the Corporation and each Corporation
Subsidiary has executed the Corporation’s standard employee proprietary
information and invention assignment agreement and each current and former
consultant to the Corporation or any Corporation Subsidiary has executed a
written agreement with the Corporation or such Corporation Subsidiary containing
invention assignment and confidentiality provisions in the Corporation’s
customary form. To the Corporation’s Knowledge, none of its or any Corporation
Subsidiary’s employees, officers or consultants are in violation of such
agreements, and no current or former officer, employee or consultant has
excluded works or inventions made prior to his or her relationship with the
Corporation or any Corporation Subsidiary that are relevant to the business of
the Corporation or any Corporation Subsidiary as conducted or as proposed to be
conducted. To the Corporation’s Knowledge, none of its or any Corporation
Subsidiary’s employees are obligated under any contract (including licenses,
covenants or commitments of any nature) or other agreement, or subject to any
judgment, decree or order of any court or administrative agency, that would
interfere with the use of his or her best efforts to promote the interests of
the Corporation and the Corporation Subsidiaries or that would conflict with the
Corporation’s or the Corporation Subsidiaries’ business as conducted or as
proposed to be conducted. Except as disclosed in Schedule 2.13, the Corporation
does not believe it is or will be necessary to utilize any inventions of any of
its or any Corporation Subsidiary’s employees (or prospective employees) or
consultants made prior to their employment by the Corporation or any Corporation
Subsidiary or prior to entering into a consulting agreement with the Corporation
or any Corporation Subsidiary, as applicable. Except as disclosed in Schedule
2.13, the employment of each officer and employee of the Corporation and any
Corporation Subsidiary is terminable at the will of the Corporation or the
applicable Corporation Subsidiary without liability for any severance payments
upon termination. To the Corporation’s Knowledge there is no impending
resignation or termination of employment of any officer, key employee or group
of employees of the Corporation or any Corporation Subsidiary. The Corporation
and each Corporation

--------------------------------------------------------------------------------

 
[exh101agreement021.jpg]
16 Subsidiary have complied in all material respects with all laws relating to
the employment of labor (including provisions relating to wages, hours, equal
opportunity, collective bargaining and the payment of social security and other
Taxes, and the Employee Retirement Income Security Act of 1974 (“ERISA”)), and
the Corporation is not aware that it or any Corporation Subsidiary has any labor
relations problems (including any union organizational activities, threatened or
actual strikes or work stoppages or grievances). Neither the Corporation nor any
of the Corporation Subsidiaries is a party to or bound by any collective
bargaining agreement or any other Contract with any labor union. None of the
Corporation, any of the Corporation Subsidiaries or, to the Knowledge of the
Corporation, any of its or their employees is subject to any noncompete,
nondisclosure, confidentiality, employment, consulting or similar agreements,
affecting or in conflict with the present business activities of the Corporation
or any Corporation Subsidiary or the proposed business activities of the
Corporation or any Corporation Subsidiary. 2.14 Employee Benefit Plans. Except
as set forth on Schedule 2.14: (a) Multiemployer Plans. Neither the Corporation
nor any Corporation Subsidiary has any obligation, and has never been required,
to contribute to (or any other liability, including current or potential
withdrawal liability, with respect to) any “multiemployer plan” (as defined in
Section 3(37) of ERISA). (b) Retiree Welfare Plans. Neither the Corporation nor
any Corporation Subsidiary maintains or has any obligation to contribute to (or
any other liability with respect to) any plan or arrangement whether or not
terminated, which provides medical, health, life insurance or other welfare-type
benefits for current or future retired or terminated employees (except for
limited continued medical benefit coverage required to be provided under Section
4980B of the Code or as required under applicable state law). (c) Defined
Benefit Plans. Neither the Corporation nor any Corporation Subsidiary maintains,
contributes to or has any liability under (or with respect to) any employee plan
that is a tax-qualified “defined benefit plan” (as defined in Section 3(35) of
ERISA), whether or not terminated. (d) Defined Contribution Plans. Neither the
Corporation nor any Corporation Subsidiary maintains, contributes to or has any
liability under (or with respect to) any employee plan that is a tax-qualified
“defined contribution plan” (as defined in Section 3(34) of ERISA), whether or
not terminated. (e) Other Plans. Neither the Corporation nor any Corporation
Subsidiary maintains, contributes to or has any liability under (or with respect
to) any plan or arrangement providing benefits to current or former employees,
including any bonus plan, profit sharing, stock option, employee stock purchase
or other plan or arrangement providing for deferred or other compensation,
employee health or other welfare benefit plan or other arrangement, or severance
agreements, programs, policies or arrangements, whether or not terminated and
whether or not subject to ERISA.

--------------------------------------------------------------------------------

 
[exh101agreement022.jpg]
17 (f) Unfunded Liability. No plan maintained by the Corporation or any
Corporation Subsidiary or to which the Corporation or any Corporation Subsidiary
has an obligation to contribute, or with respect to which the Corporation or any
Corporation Subsidiary has any other liability, has any unfunded liability. (g)
Plan Qualification and Compliance. None of the employee benefit plans set forth
on Schedule 2.14 is intended to be qualified under Section 401(a) of the Code.
Each employee benefit plan set forth on Schedule 2.14 and all related trusts,
insurance contracts and funds have been maintained, funded and administered in
material compliance with their respective terms and with all applicable laws.
For purposes of this Section 2.14, the term “Corporation” includes all entities
under common control with the Corporation pursuant to Section 414(b) or (c) of
the Code. 2.15 Taxes. (a) (i) The Corporation and each Corporation Subsidiary
has timely filed all Tax Returns required to be filed by it; (ii) all such Tax
Returns are complete and accurate in all material respects, disclose all Taxes
required to be paid by the Corporation or any Corporation Subsidiary, for the
periods covered thereby and have been prepared in compliance with all applicable
laws and regulations; (iii) the Corporation and each Corporation Subsidiary has
timely paid all Taxes (whether or not shown on such Tax Returns) due and owing
by it and has withheld and paid over to the appropriate taxing authority all
Taxes that it is required by law to withhold or to collect for payment from
amounts paid or owing to any employee, stockholder, creditor or other third
party; (iv) neither the Corporation nor any Corporation Subsidiary has waived or
been requested to waive any statute of limitations in respect of Taxes which
waiver is currently in effect; (v) neither the Corporation nor any Corporation
Subsidiary is currently the beneficiary of any extension of time within which to
file any Tax Return; (vi) there is no action, suit, investigation, audit, claim
or assessment pending or, to the Knowledge of the Corporation, proposed or
threatened with respect to Taxes of the Corporation or any Corporation
Subsidiary and no information related to Tax matters has been requested by any
foreign, Federal, state or local taxing authority; (vii) there are no Liens for
Taxes upon the assets or properties of the Corporation nor any Corporation
Subsidiary except Liens relating to current Taxes not yet due; and (viii) there
are no material unresolved questions or claims concerning any Tax liability of
the Corporation or any Corporation Subsidiary. (b) Neither the Corporation nor
any Corporation Subsidiary is liable for the Taxes of another Person in a
material amount (i) under Treasury Regulation § 1.1502-6 (or comparable
provisions of state, local or foreign law), (ii) as a transferee or successor,
or (iii) by contract or indemnity or otherwise. Except as set forth on Schedule
2.15(b), neither the Corporation nor any Corporation Subsidiary is a party to
any Tax sharing or indemnity agreements. Neither the Corporation nor any
Corporation Subsidiary has been a member of any affiliated group as defined in
Section 1504 of the Code that has filed a consolidated return for Federal income
tax purposes (or any similar group under state, local or foreign law). Neither
the Corporation nor any Corporation Subsidiary has made any payments, or is
obligated to make payments or is a party to an agreement that could obligate it
to make any payments that would not be deductible under Section 280G of the
Code.

--------------------------------------------------------------------------------

 
[exh101agreement023.jpg]
18 2.16 Insurance. The Corporation and the Corporation Subsidiaries have
maintained insurance in such types and amounts as appropriate for their
respective businesses. Neither the Corporation nor any Corporation Subsidiary
has any self-insurance or co-insurance programs. Neither the Corporation nor any
Corporation Subsidiary has been refused any insurance coverage sought or applied
for and neither the Corporation nor any Corporation Subsidiary has any reason to
believe that it will not be able to renew its existing insurance coverage as and
when such coverage expires or to obtain similar coverage from similar insurers
as may be necessary to continue its business at a cost that would not have a
Material Adverse Effect. 2.17 Claims. (a) The Corporation and the Corporation
Subsidiaries have sole and exclusive ownership of the Claims. No stockholder or
other Affiliate of the Corporation or any Corporation Subsidiary has any
ownership interest in the Claims. Neither the Corporation nor any Corporation
Subsidiary, nor any Person on their behalf, has assigned, transferred, pledged,
encumbered or given, as collateral or otherwise, to any Person, any right or
interest of the Corporation or any Corporation Subsidiary in the Claims or the
Proceeds. (b) There are no Persons who have Liens of any kind against any amount
to which the Corporation or any Corporation Subsidiary may be entitled on
account of the Claims and/or Proceedings. 2.18 Negative Litigation Event. As of
the date hereof, no Negative Litigation Event has occurred, and neither the
Corporation nor any of its Subsidiaries is aware of any facts that indicate a
reasonable likelihood of the occurrence of a Negative Litigation Event. 2.19
Brokers or Finders. Except as set forth on Schedule 2.19, neither the
Corporation nor any Corporation Subsidiary has engaged any brokers, finders or
agents, and the Purchaser have not incurred, and will not incur, directly or
indirectly, as a result of any action taken by the Corporation or any
Corporation Subsidiary, any liability for brokerage or finders’ fees or agents’
commissions or any similar charges in connection with the transactions
contemplated by or under this Agreement and the other Transaction Documents.
2.20 Offering. Subject to the accuracy of the Purchaser’s representations and
warranties in Section 3, the offer, sale and issuance of the Securities to be
issued in conformity with the terms of this Agreement will constitute
transactions exempt from the registration requirements of Section 5 of the
Securities Act and are in compliance with all applicable securities laws of the
United States and are in compliance with and will have been registered or
qualified (or are exempt from registration or qualification) under the
registration, permit or qualification requirements of all applicable securities
laws of each of the states whose laws govern the issuance of the Securities.
Neither the Corporation nor any agent on its behalf has (i) solicited or will
solicit any offers to sell or has offered to sell or will offer to sell all or
part of the Securities to any person or persons so as to bring the sale of such
Securities by the Corporation within the registration provisions of the
Securities Act or any state securities laws or (ii) engaged in any form of
general solicitation or general advertising (within the meaning of Regulation D
under the Securities Act) in connection with the offer or sale of the
Securities. None of the Corporation, any of its Affiliates or any Person acting

--------------------------------------------------------------------------------

 
[exh101agreement024.jpg]
19 on its or their behalf, has directly or indirectly made any offers or sales
of any security or solicited any offers to buy any security under circumstances
that would require registration of the Securities or cause this offering of
Securities to be integrated with any prior offering of the Corporation’s
securities. 2.21 Disclosure. Neither this Agreement (including all the exhibits
and schedules hereto) nor any related agreements nor any certificates or other
information delivered in connection herewith contains any untrue statement of a
material fact or omits to state a material fact necessary to make the statements
herein or therein not misleading in light of the circumstances under which they
were made. 3. Representations and Warranties of the Purchaser. As an inducement
to the Corporation to enter into this Agreement and to issue and sell the
Securities, the Purchaser hereby represents and warrants to the Corporation as
follows: 3.1 Organization. The Purchaser is a Delaware limited liability company
and is duly organized, validly existing and in good standing under the laws of
its jurisdiction of incorporation or formation. 3.2 Authorization. (a) The
Purchaser has all requisite legal and corporate power and authority to execute
and deliver this Agreement and each of the other Transaction Documents to which
it is a party, to purchase the Securities hereunder and to carry out and perform
its obligations under the terms of this Agreement and each of the other
Transaction Documents to which it is a party. All action on the part of the
Purchaser necessary for the authorization, execution, delivery and performance
of this Agreement and each of the other Transaction Documents to which it is a
party and the performance of all of the Purchaser’s obligations under this
Agreement and each of the other Transaction Documents to which it is a party,
has been taken. (b) This Agreement and each of the other Transaction Documents
to which it is a party, when executed and delivered by the Purchaser, shall
constitute valid and binding obligations of the Purchaser, enforceable against
the Purchaser in accordance with their terms except as such enforceability may
be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws
affecting creditors’ rights generally and by general equitable principles. (c)
No consent, approval, authorization, order, filing, registration or
qualification of or with any court, Governmental Entity or third person is
required to be obtained by the Purchaser in connection with the execution and
delivery of this Agreement and each of the other Transaction Documents to which
it is a party, or the performance of the Purchaser’s obligations hereunder or
thereunder. 3.3 Accredited Investor. The Purchaser is an “accredited investor”
as defined in Rule 501(a) of Regulation D under the Securities Act on the basis
indicated therein. 3.4 Restriction on Resale The Purchaser acknowledges that the
Shares and the Warrant Shares must be held indefinitely unless subsequently
registered under the Securities Act or

--------------------------------------------------------------------------------

 
[exh101agreement025.jpg]
20 unless an exemption from such registration is available. The Purchaser
further understands that there is no assurance that any exemption from
registration under the Securities Act will be available to a resale of the
Shares and the Warrant Shares by the Purchaser or, if available, that such
exemption will allow the Purchaser to dispose of or otherwise transfer any or
all of the Shares and the Warrant Shares in the amounts or at the times the
Purchaser might propose. The Purchaser understands and acknowledges that no
public market now exists for the Shares and that the Corporation has made no
assurances that a public market will ever exist for the Shares. 3.5 Legends. The
Purchaser understands and agrees that the certificates evidencing the Shares, or
any other securities issued in respect of the Shares upon any stock split, stock
dividend, recapitalization, merger, consolidation or similar event, shall bear
the legends set forth in Section 5.1. 3.6 Brokers or Finders. The Corporation
will not incur, as a result of any action taken by the Purchaser, any liability
for brokerage or finders’ fees or agents’ commissions or any similar charges in
connection with the transactions contemplated by or under this Agreement and the
other Transaction Documents. 4. Covenants; Purchaser Rights. 4.1 Information
Rights. (a) Financial Statements. Following the Closing, and so long as the
Purchaser continues to hold 20% or more of the Shares originally issued to the
Purchaser at the Closing, the Corporation shall be required to deliver to the
Purchaser (whether in hard copy, by e- mail or e-mail notification that the
applicable information is available on the SEC’s EDGAR site) the following
information: (i) As soon as available, and in any event within 90 days after the
end of each Fiscal Year, the audited balance sheet of the Corporation as at the
end of each such Fiscal Year and the audited statements of income, cash flows
and changes in stockholders’ equity for such year, accompanied by the
certification of an independent certified public accountant of recognized
national standing, to the effect that, except as set forth therein, such
financial statements have been prepared in accordance with GAAP, applied on a
basis consistent with prior years and fairly present in all material respects
the financial condition of the Corporation as of the dates thereof and the
results of its operations and changes in its cash flows and stockholders’ equity
for the periods covered thereby. Purchaser hereby acknowledges and agrees that
Marcum LLP, the Corporation’s independent registered public accounting firm, is
of recognized national standing. (ii) As soon as available, and in any event
within 45 days after the end of each fiscal quarter, the balance sheet of the
Corporation at the end of such quarter and the statements of income, cash flows
and changes in stockholders’ equity for such quarter, all in reasonable detail
and all prepared in accordance with GAAP, consistently applied, and certified by
the Chief Financial Officer of the Corporation.

--------------------------------------------------------------------------------

 
[exh101agreement026.jpg]
21 (iii) As soon as available, and in any event on or prior to the Corporation’s
quarterly Board meetings, such additional financial information of the
Corporation as presented to the Board at such meetings. (iv) To the extent the
Corporation is required by Requirements of Law or pursuant to the terms of any
outstanding indebtedness of the Corporation to prepare such reports, any annual
reports, quarterly reports and other periodic reports (without exhibits)
actually prepared by the Corporation as soon as available. (v) No later than 30
days prior to the start of each Fiscal Year, an annual budget, which shall
include consolidated capital and operating expense budgets, cash flow
projections and income and loss projections for the Corporation in respect of
such Fiscal Year, all itemized in reasonable detail and prepared on a monthly
basis, and, promptly after preparation, any revisions to any of the foregoing.
(vi) Promptly following receipt by the Corporation, each audit response letter,
accountant’s management letter or other written support submitted to the
Corporation by its independent public accountants in connection with an annual
or interim audit of the books of the Corporation. (vii) Promptly after
commencement thereof, notice of all actions, suits, claims, proceedings,
investigations and inquiries involving the Corporation or any Corporation
Subsidiary that would reasonably be expected to materially adversely affect the
Corporation or such Corporation Subsidiary. (viii) Promptly after request by the
Purchaser, such additional financial information of the Corporation as Purchaser
may be request to determine whether a Negative Treasury Event has occurred. (ix)
Within one Business Day of becoming aware thereof, written notice of a Negative
Treasury Event; (x) Written notice within five Business Days of becoming aware
of any material change in any of the information contained in the
representations and warranties and/or Exhibits to this Agreement. (b) Inspection
Rights. Following the Closing, and so long as the Purchaser continues to hold
20% or more of the Shares originally issued to the Purchaser at the Closing, the
Corporation shall, and shall cause the Corporation Subsidiaries and each of
their respective officers, directors, managers and employees to, (i) afford the
Purchaser and its representatives, during normal business hours and upon
reasonable notice, reasonable access to its officers, employees, auditors,
properties, offices, plants and other facilities and to all books and records,
and (ii) afford the Purchaser the opportunity to consult with its officers from
time to time regarding the Corporation’s and the Corporation Subsidiaries’
affairs, finances and accounts as each the Purchaser may reasonably request upon
reasonable notice. Any information disclosed to the Purchaser (or its
representatives) shall be subject to an appropriate confidentiality agreement.
The

--------------------------------------------------------------------------------

 
[exh101agreement027.jpg]
22 Purchaser (and its representatives) shall take reasonable steps, to the
extent commercially practicable, to minimize the disruption caused by any such
inspection. The right set forth in this Section 4.1 shall not and is not
intended to limit any rights which the Purchaser may have with respect to the
books and records of the Corporation, or to inspect its properties or discuss
its affairs, finances and accounts under the laws of the jurisdiction in which
the Corporation is incorporated. 4.2 Board of Directors Rights. Upon the
earliest to occur of (x) a Negative Litigation Event, (y) a Negative Treasury
Event or (z) the Corporation has not paid the Liquidation Preference (as defined
in the Certificate of Designation) on or prior to such time that the Liquidation
Preference is greater than or equal to 2.8 times the Purchase Price (so long as,
in the case of this clause (z), the Purchaser continues to hold 20% or more of
the Shares originally issued to the Purchaser at the Closing), the following
provisions shall apply: (a) The Purchaser shall have the right to designate a
total of one Person to serve as a member of the Board of Directors (the
“Nominee”). The Corporation shall promptly (and in any event within ten (10)
Business Days of request by the Purchaser) (i) increase the size of the Board of
Directors, if necessary, and (ii) appoint such Nominee to the Board of
Directors. If at the time of such appointment the Corporation has a staggered
Board of Directors, such Nominee shall be appointed to the class of the Board of
Directors that has the longest remaining term at the time of such appointment.
(b) The Corporation shall take (and cause to be taken) all actions and agrees to
exercise all authority under Requirements of Law to cause any slate of directors
presented to stockholders of the Corporation for election to the Board of
Directors to include the Nominee. In this regard, the Corporation shall, subject
to Requirements of Law, duly nominate the Nominee for election to the Board of
Directors and shall solicit proxies in favor of the election of the Nominee from
the stockholders of the Corporation entitled to vote for the election of
directors. In connection therewith and in furtherance thereof, the Corporation
shall include in any proxy solicitation materials related to the election of
members of the Board of Directors such information regarding the Nominee and
recommendations of the Board of Directors as are appropriate in proxy
solicitation materials or as may be required under the rules and regulations
promulgated by the SEC. (c) Following the election of a Nominee to the Board of
Directors and so long as Shares remain outstanding, such Nominee shall not be
removed from the Board of Directors except by the Purchaser. Upon the
resignation, removal by the Purchaser, death or disability of a Nominee serving
as a director of the Board of Directors, the Purchaser shall have the right to
designate a replacement Nominee and either the remaining directors on the Board
of Directors shall promptly (and in any event within ten Business Days) appoint
such replacement Nominee to fill the vacancy on the Board of Directors or, if
the remaining directors fail to appoint such replacement Nominee to fill such
vacancy, then the Corporation shall duly nominate such replacement Nominee for
election to the Board of Directors pursuant to Section 4.2(b), and, if
reasonably requested by the Purchaser in order to elect or appoint such nominee,
promptly call (or cause to be called) and hold a special meeting of the
Corporation’s stockholders for the purpose of voting on such replacement
Nominee.

--------------------------------------------------------------------------------

 
[exh101agreement028.jpg]
23 4.3 Board Observer Rights. For so long as the Purchaser continues to hold 20%
or more of the Shares originally issued to the Purchaser at the Closing, the
Purchaser shall have the right to designate one representative (an “Observer”)
with the right to attend and observe all meetings of the Board of Directors or
committees designated by the Board of Directors. The Corporation shall promptly
invite (or cause to be invited) the Observer to attend all meetings of the Board
of Directors or any committee thereof and, in this respect, shall give (or cause
to be given) to the Observer copies of all notices, minutes, consents, and other
material that the Corporation provides to its directors at the same time as such
materials are provided to its directors. Notwithstanding the foregoing, the
Corporation reserves the right to exclude the Observer from access to any
material or meeting or portion thereof if and only to the extent the Corporation
believes that such exclusion is reasonably necessary to preserve the
attorney-client privilege. 4.4 Preemptive Rights. (a) Following the Closing, the
Purchaser shall have the right to purchase any New Securities that the
Corporation or any Corporation Subsidiary may from time to time propose to issue
or sell to any Person. (b) At least thirty (30) Business Days prior to any
issuance or sale referred to in Section 4.4(a), the Corporation shall notify in
writing the Purchaser of such proposed issuance or sale (the “Preemptive Right
Notice”). The Preemptive Right Notice shall describe the proposed issuance or
sale and the material terms and conditions thereof, including: (i) the number of
New Securities proposed to be issued and the percentage of the Corporation's or
such Corporation Subsidiary’s outstanding Common Stock, as applicable, on a
fully diluted basis, that such issuance would represent; (ii) the proposed
issuance date, which shall be at least thirty (30) Business Days from the date
of the Preemptive Right Notice; (iii) the proposed purchase price per share and
(iv) a summary of the material terms of such New Securities. The Purchaser shall
for a period of twenty (20) Business Days following the receipt of a Preemptive
Right Notice (the “Exercise Period”) have the right to elect irrevocably to
purchase, at the purchase price set forth in the Preemptive Right Notice, all or
any portion of such New Securities, by delivering a written notice to the
Corporation. (c) Subject to the Certificate of Designation, the Corporation
shall be free to complete the proposed issuance or sale of New Securities
described in the Preemptive Right Notice with respect to any New Securities not
elected to be purchased pursuant to Section 4.4(b) above in accordance with the
terms and conditions set forth in the Preemptive Right Notice (except that the
amount of New Securities to be issued or sold by the Corporation may be reduced)
so long as such issuance or sale is closed within sixty (60) Business Days after
the expiration of the Exercise Period (subject to the extension of such sixty
(60) Business Day period for a reasonable time not to exceed thirty (30) days to
the extent reasonably necessary to obtain necessary approvals from Governmental
Entities). In the event the Corporation has not sold such New Securities within
such time period, the Corporation shall not thereafter issue or sell any New
Securities without first again offering such securities to the Stockholders in
accordance with the procedures set forth in this Section 4.4. (d) Upon the
consummation of the issuance of any New Securities in accordance with this
Section 4.4, the Corporation shall deliver to the Purchaser certificates (if
any)

--------------------------------------------------------------------------------

 
[exh101agreement029.jpg]
24 evidencing the New Securities, which New Securities shall be issued free and
clear of any Liens (other than those arising hereunder and those attributable to
the actions of the purchasers thereof), and the Corporation shall so represent
and warrant to the purchaser thereof, and further represent and warrant to such
purchaser that such New Securities shall be, upon issuance thereof to the
Purchaser and after payment therefor, duly authorized, validly issued, fully
paid and non-assessable. The Purchaser shall deliver to the Corporation the
purchase price for the New Securities purchased by wire transfer of immediately
available funds. Each party to the purchase and sale of New Securities shall
take all such other actions as may be reasonably necessary to consummate the
purchase and sale including entering into such additional agreements as may be
necessary or appropriate. 4.5 Reporting Status. The Corporation shall comply
with all Requirements of Law, including the rules and regulations under the
Securities Act and the Exchange Act, and the rules of any securities exchange
upon which any shares of its capital stock are listed. The Corporation shall use
commercially reasonable efforts to maintain its status as a company with
securities registered under Section 12 of the Exchange Act and the quotation of
the Common Stock on NASDAQ, and shall timely file all reports and other filings
required to be filed by it under the Securities Act and the Exchange Act, the
rules and regulations adopted by the SEC thereunder or the rules and regulations
of NASDAQ. If required, the Company shall promptly file the “Listing
Application” for, or in connection with, the issuance and delivery of the
Warrant Shares. The Corporation shall take such further action as the Purchaser
may reasonably request to enable such holders to sell Restricted Securities
pursuant to Rule 144 adopted by the SEC under the Securities Act (as such rule
may be amended from time to time) or any similar rule or regulation hereafter
adopted by the SEC. Upon reasonable request, the Corporation shall deliver to
any holder of Restricted Securities a written statement as to whether it has
complied with such requirements. 4.6 Public Disclosure of Transaction. On or
before 5:30 p.m., New York City time, on or before the Fourth Business Day
immediately following the date hereof, the Corporation shall issue a press
release announcing the entry into this Agreement and describing the terms of the
transactions contemplated hereby and by the other Transaction Documents. 4.7
Pursuit of the Claims. The Corporation shall use its commercially reasonable
best efforts and exercise good faith and reasonable commercial judgment, but at
all times within the bounds of any applicable law and rules of professional
responsibility: (i) in pursuing all of the Corporation’s and the Corporation
Subsidiaries’ or any of their respective Affiliates’ legal and equitable rights
in the Claims and/or Proceedings and with respect to the Proceeds; (ii) to bring
the Claims and/or Proceedings to settlement or final judgment; and (iii) to
enforce collection of all money and other Proceeds due on account of the Claims
and/or Proceedings or other enforcement actions relating to the Proceeds,
including any settlement(s) with Adverse Parties. The Corporation shall maintain
and prosecute the Patents. 4.8 Preserve Accuracy of Representations and
Warranties; Notification of Certain Matters. (a) During the period prior to the
Closing Date, each party hereto shall refrain from taking any action which would
render any representation or warranty contained in Sections 2 or 3, as
applicable, inaccurate as of the Closing Date. Each party shall promptly notify
the

--------------------------------------------------------------------------------

 
[exh101agreement030.jpg]
25 other of any action, suit or proceeding that shall be instituted or
threatened against such party to restrain, prohibit or otherwise challenge the
legality of any transaction contemplated by this Agreement. (b) During the
period prior to the Closing Date, the Corporation will notify the Purchaser of
(i) any Material Adverse Effect, (ii) any lawsuit, claim, proceeding or
investigation that is threatened, brought, asserted or commenced against the
Corporation which would have been listed in Schedule 2.8 if such lawsuit, claim,
proceeding or investigation had arisen prior to the date hereof, (iii) any
notice or other communication from any third Person alleging that the consent of
such third Person is or may be required in connection with the transactions
contemplated by this Agreement, and (iv) any material default under any
agreement of the Corporation or any Corporation Subsidiary or event which, with
notice or lapse of time or both, would become such a default on or prior to the
Closing Date and of which the Corporation has Knowledge. 4.9 Operations Prior to
the Closing Date. During the period prior to the Closing Date, the Corporation
shall operate and carry on its and the Corporation Subsidiaries’ business only
in the ordinary course and substantially as presently operated. Consistent with
the foregoing, the Corporation shall keep and maintain its assets in good
operating condition and repair and shall use its commercially reasonable best
efforts consistent with good business practice to maintain the business
organization of the Corporation and the Corporation Subsidiaries intact and to
preserve the goodwill of the suppliers, contractors, licensors, licensees,
employees, customers, distributors and others having business relations with the
Corporation or the Corporation Subsidiaries. 4.10 Acquisition Proposals. During
the period prior to the Closing Date, the Corporation shall not, and shall not
authorize or permit any officer, director, employee or Affiliate of the
Corporation , or authorize any investment banker, attorney, accountant or other
representative retained by the Corporation or any Affiliate of the Corporation,
to, directly or indirectly, solicit or encourage, or furnish information with
respect to the Corporation to, or engage in any discussions with, any Person in
connection with any proposal for the acquisition of all or a substantial portion
of the Corporation or any financing transaction involving the Corporation, other
than as contemplated by this Agreement. The Corporation shall promptly cease or
cause to be terminated any existing activities or discussions with any Person
with respect to any of the foregoing. 5. Transfer Restrictions. (a) Subject to
compliance with applicable securities laws, the Shares and the Warrant shall not
be Transferable to any Person other than an Affiliate of the Purchaser. (b) Each
certificate or instrument representing Restricted Securities shall be imprinted
with a legend in substantially the following form: “THE SECURITIES REPRESENTED
BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
AS AMENDED (THE “ACT”), OR UNDER APPLICABLE STATE SECURITIES LAWS, AND MAY NOT
BE SOLD, ASSIGNED, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN

--------------------------------------------------------------------------------

 
[exh101agreement031.jpg]
26 EFFECTIVE REGISTRATION UNDER THE ACT OR IN A TRANSACTION WHICH QUALIFIES AS
AN EXEMPT TRANSACTION UNDER THE ACT, THE RULES AND REGULATIONS PROMULGATED
THEREUNDER AND THE SECURITIES LAW OF ANY APPLICABLE STATE.” (c) If any
Restricted Securities become eligible for sale pursuant to Rule 144(b), the
Corporation shall, upon the reasonable request of the holder of such Restricted
Securities, remove the legend set forth in Section 5(b) from the certificates
for such Restricted Securities. 6. Conditions to the Purchaser’s Obligations at
Closing. The obligations of the Purchaser to purchase the Shares and the Warrant
at the Closing are subject to the fulfillment, on or before such Closing, of
each of the following conditions, unless waived by the Purchaser: 6.1
Representations and Warranties; Covenants. The representations and warranties of
the Corporation contained in Section 2 shall be true and correct in all respects
as of the date of Closing. The Corporation shall have complied with each of its
covenants set forth herein. 6.2 Consents, Permits and Waivers. The Corporation
shall have obtained any and all consents, permits and waivers necessary or
appropriate for consummation of the transactions contemplated hereby and by the
other Transaction Documents. 6.3 No Prohibitions. No provision of any
Requirements of Law and no order, injunction, temporary restraining order,
judgment, award, decree or ruling of any Governmental Entity shall prohibit or
otherwise challenge the legality or validity of the transactions contemplated by
this Agreement. 6.4 Blue Sky. The Corporation shall have obtained all necessary
blue sky law permits and qualifications, or have the availability of exemptions
therefrom, required by any Governmental Entity or regulatory body of the United
States or of any state or foreign jurisdiction that are required in connection
with the lawful offer, sale and issuance of the Securities. 6.5 Certificate of
Designation. The Certificate of Designation shall have been filed with and
certified by the Secretary of State of the State of Delaware. 6.6 Other. The
Purchaser shall have received a correct and complete copy of the items set forth
on Schedule 6.6 and the Purchaser shall be satisfied with the contents thereof
in its sole and absolute discretion. 6.7 Schedules. The Corporation shall have
delivered correct and complete copies of all schedules contemplated hereunder
and the Purchaser shall be satisfied with the contents thereof in its sole and
absolute discretion. 6.8 Closing Deliverables. At the Closing, the Corporation
shall have delivered to the Purchaser, the following:

--------------------------------------------------------------------------------

 
[exh101agreement032.jpg]
27 (a) a certificate executed by the Chief Executive Officer of the Corporation
on behalf of the Corporation, certifying the satisfaction of the conditions to
closing listed in Sections 6.1, 6.2, 6.4 and 6.5; (b) a certificate executed by
the Corporation’s Secretary on behalf of the Corporation having attached thereto
(i) the Corporation’s Amended and Restated Certificate as in effect at the time
of the Closing, including a copy of the as filed Certificate of Designation,
certified by the Secretary of State of the State of Delaware, (ii) the
Corporation’s Bylaws as in effect at the time of the Closing, and (iii)
resolutions approved by the Board of Directors authorizing the transactions
contemplated hereby; (c) good standing certificates with respect to the
Corporation from the applicable authority(ies) in Delaware and any other
jurisdiction in which the Corporation is qualified to do business, dated a
recent date before the Closing; (d) to the Purchaser, free and clear of all
Liens, a stock certificate, duly executed by the Corporation, evidencing 153,000
Shares; and (e) to the Purchaser, free and clear of all Liens, the Warrant, duly
executed by the Corporation, to purchase 2,000,000 shares of Common Stock at the
exercise price and upon the terms and conditions set forth therein. 6.9
Proceedings and Documents. All corporate and other proceedings in connection
with the transactions contemplated at the Closing hereby and all documents and
instruments incident to such transactions shall be reasonably satisfactory in
substance and form to the Purchaser, and the Purchaser shall have received all
such counterpart originals or certified or other copies of such documents as
they may reasonably request. 7. Conditions to the Corporation’s Obligations at
Closing. The Corporation’s obligation to sell and issue the Shares and the
Warrant at Closing to the Purchaser is subject to the fulfillment on or before
the Closing of the following conditions, unless waived by the Corporation: 7.1
Representations and Warranties. The representations and warranties of the
Purchaser contained in Section 3 shall be true and correct in all respects as of
the Closing. 7.2 No Prohibitions. No provision of any Requirements of Law or
ruling of any Governmental Entity shall prohibit or otherwise challenge the
legality or validity of the transactions contemplated by this Agreement. 7.3
Closing Deliverables. At the Closing, the Purchaser shall have (a) delivered to
the Corporation (i) all such counterpart originals or certified or other copies
of this Agreement, the other Transaction Documents to which the Purchaser is a
party and such other documents as the Corporation may reasonably request, and
(ii) a certificate executed by the Purchaser certifying the satisfaction of the
condition to closing listed in Section 7.1. 8. Termination of the Agreement
Prior to Closing.

--------------------------------------------------------------------------------

 
[exh101agreement033.jpg]
28 8.1 Termination Triggers. Notwithstanding anything to the contrary herein,
this Agreement may be terminated (i) by either party at any time after the
twentieth (20th) Business Day following the date hereof if the Closing shall not
have occurred by such date; provided, however, that if the Closing shall not
have occurred as a result of the failure of the conditions set forth in Section
6 to be satisfied by such date, then the Purchaser may extend such date in its
sole discretion, (ii) by the mutual written consent of the Corporation and the
Purchaser or (iii) by either party upon the breach of any representation,
warranty or covenant set forth herein by the other party that would result in
the failure of the conditions set forth in Sections 6 or 7 (as applicable) to be
satisfied. 8.2 Effect of Termination. In the event of termination of this
Agreement as provided in Section 8.1, this Agreement shall forthwith become void
and there shall be no liability on the part of any party hereto as to which such
termination has occurred; provided, however, that nothing herein shall relieve
any party from liability for any breach of this Agreement or the Corporation of
its obligations under Section 9.9. 9. Miscellaneous. 9.1 Indemnification. (a) In
addition to all rights and remedies available to the Purchaser at law or in
equity, the Corporation shall indemnify the Purchaser and its Affiliates,
stockholders, members, officers, directors, managers, partners, employees,
agents, representatives, heirs, successors and assigns (each an “Indemnified
Party,” and collectively, the “Indemnified Parties”) and shall save and hold
each of them harmless against, and pay on behalf of or reimburse such party as
and when incurred for, any loss, liability, obligation, demand, claim, action,
cause of action, proceeding, judgment, settlement, cost (including attorneys’
fees), damage, deficiency, Tax, penalty, fine, expense, or disbursement, whether
or not arising out of any claims by or on behalf of any third party, including
interest, penalties, reasonable attorneys’ fees and expenses, and all reasonable
amounts paid in investigation, defense, or settlement of any of the foregoing
(collectively, “Losses”) which any such party may suffer, sustain, or become
subject to, as a result of, in connection with, relating or incidental to, or by
virtue of: (i) Any misrepresentation or breach of a representation or warranty
on the part of the Corporation under Section 2 or any certificate delivered
hereunder; or (ii) Any nonfulfillment or breach of any covenant or agreement on
the part of the Corporation under this Agreement or under any of the other
Transaction Documents. (b) The obligations of the Corporation to each
Indemnified Party under this Section 9.1 will be separate and distinct
obligations and will survive any transfer of the Shares by the Purchaser and the
expiration or termination of this Agreement or any other Transaction Document.

--------------------------------------------------------------------------------

 
[exh101agreement034.jpg]
29 9.2 Survival of Warranties. The warranties, representations and covenants of
the Corporation and Purchaser contained in or made pursuant to this Agreement
shall survive the execution and delivery of this Agreement and the Closing and
shall in no way be affected by any investigation or knowledge of the subject
matter thereof made by or on behalf of the Purchaser or the Corporation. 9.3
Successors and Assigns. The terms and conditions of this Agreement shall inure
to the benefit of and be binding upon the respective successors and assigns of
the parties. Nothing in this Agreement, express or implied, is intended to
confer upon any party other than the parties hereto or their respective
successors and assigns any rights, remedies, obligations, or liabilities under
or by reason of this Agreement, except as expressly provided in this Agreement.
9.4 Governing Law and Jurisdiction. This Agreement and any controversy arising
out of or relating to this Agreement shall be governed by and construed in
accordance with the internal laws of the State of State of New York, without
regard to conflict of law principles that would result in the application of any
law other than the law of the State of New York, with the Corporation and the
Purchaser hereby agreeing to personal jurisdiction and venue in such court of
competent jurisdiction in the federal and state courts of the City of New York,
New York. 9.5 Counterparts; Facsimile or PDF. This Agreement may be executed and
delivered by facsimile, PDF signature or electronic signature and in two or more
counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument. 9.6 Titles and Subtitles.
The titles and subtitles used in this Agreement are used for convenience only
and are not to be considered in construing or interpreting this Agreement. 9.7
Disclosure Schedules. The Disclosure Schedules shall be arranged in sections
corresponding to the numbered and lettered sections and subsections contained in
Section 2. 9.8 Notices. All notices and other communications given or made
pursuant to this Agreement shall be in writing and shall be deemed effectively
given upon the earlier of actual receipt or (a) personal delivery to the party
to be notified, (b) when sent, if sent by electronic mail or facsimile during
normal business hours of the recipient, and if not sent during normal business
hours, then on the recipient’s next Business Day, (c) the next business day upon
deposit with a reputable national overnight delivery service for overnight
delivery, (d) five (5) days after having been sent by certified or registered
mail, return receipt requested, postage prepaid, to be sent as follows: If to
the Purchaser: Soryn HLDR Vehicle II LLC Attention: Chief Compliance Officer 477
Madison Avenue, 8th Floor New York, New York 10022 Email:
smcdermott@halcyonllc.com Facsimile: 212-935-1831

--------------------------------------------------------------------------------

 
[exh101agreement035.jpg]
30 If to the Corporation: Finjan Holdings, Inc. Attention: Chief Executive
Officer 2000 University Avenue, Suite 600 East Palo Alto, California 94303
Email: phil@finjan.com with copies to (which shall not constitute notice): GCA
Law Partners LLP 2570 W. El Camino Real, Suite 510 Mountain View, California
94040 Attention: Jon C. Gonzales Email: jgonzales@gcalaw.com Facsimile:
650-428-3901 9.9 Expenses. The Corporation shall pay up to a total of $125,000
of the Purchaser’s reasonable and documented fees and expenses (the “Purchaser
Expenses”) in connection with this Agreement and the transactions contemplated
hereby (it being agreed and understood that, at the Purchaser’s option, the
amount of the Purchaser Expenses shall be payable by offsetting the amount due
from the Purchaser pursuant Section 1.2(c)). 9.10 Origination Fee. The
Corporation shall pay the Purchaser an origination fee equal to $300,000 (the
“Origination Fee”) in connection with this Agreement and the transactions
contemplated hereby (it being agreed and understood that, at the Purchaser’s
option, the amount of the Origination Fee shall be payable by offsetting the
amount due from the Purchaser pursuant Section 1.2(c)). 9.11 Remedies;
Attorneys’ Fees. If any action at law or in equity (including arbitration) is
necessary to enforce or interpret the terms of this Agreement or any of the
other Transaction Documents, the prevailing party shall be entitled to
reasonable attorneys’ fees, costs and necessary disbursements in addition to any
other relief to which such party may be entitled. The Purchaser shall be
entitled to enforce any rights it has under this Agreement or the Transaction
Documents specifically (without posting a bond or other security), to recover
damages by reason of any breach of any provision of this Agreement and to
exercise all other rights granted by law. 9.12 Amendments and Waivers. Except as
expressly provided herein, any term of this Agreement may be amended, terminated
or waived only with the written consent of the Corporation and (i) the holders
of at least a majority of the then-outstanding Shares or (ii) for an amendment,
termination or waiver effected prior to the Closing, the Purchaser. Any
amendment or waiver effected in accordance with this Section 9.12 shall be
binding upon the Purchaser and each transferee of the Shares, each future holder
of all such securities, and the Corporation. 9.13 Confidentiality. The parties
will keep confidential the Confidential Information (which obligation shall
continue for a period of 1 year following the redemption of all

--------------------------------------------------------------------------------

 
[exh101agreement036.jpg]
31 Shares) save that such Confidential Information may be disclosed: (a) if so
required by any court of competent jurisdiction or any competent judicial,
governmental, supervisory or regulatory body with jurisdiction over the affairs
of the Purchaser or any Affiliate of the Purchaser; (b) if required in
connection with any legal proceedings; or (c) to Affiliates and representatives
of Purchaser who have a specific need to review such Confidential Information
for legal or compliance reasons. The parties agree not to use any Confidential
Information for any unlawful purpose. 9.14 Severability. The invalidity or
unenforceability of any provision hereof shall in no way affect the validity or
enforceability of any other provision. 9.15 Delays or Omissions. No delay or
omission to exercise any right, power or remedy accruing to any party under this
Agreement, upon any breach or default of any other party under this Agreement,
shall impair any such right, power or remedy of such non-breaching or non-
defaulting party nor shall it be construed to be a waiver of any such breach or
default, or an acquiescence therein, or of or in any similar breach or default
thereafter occurring; nor shall any waiver of any single breach or default be
deemed a waiver of any other breach or default theretofore or thereafter
occurring. Any waiver, permit, consent or approval of any kind or character on
the part of any party of any breach or default under this Agreement, or any
waiver on the part of any party of any provisions or conditions of this
Agreement, must be in writing and shall be effective only to the extent
specifically set forth in such writing. All remedies, either under this
Agreement or by law or otherwise afforded to any party, shall be cumulative and
not alternative. 9.16 Rights of Purchaser. The Purchaser shall have the absolute
right to exercise or refrain from exercising any right or rights that the
Purchaser may have by reason of this Agreement or the other Transaction
Documents, the Amended and Restated Certificate, the Bylaws, or at law or in
equity, including the right to consent to the waiver of any obligation of the
Corporation and to enter into an agreement with the Corporation for the purpose
of modifying this Agreement or the other Transaction Documents, and the
Purchaser shall not incur any liability to any other holder of Shares with
respect to exercising or refraining from exercising any such right or rights.
9.17 Exchange of Certificates. Upon surrender by any holder to the Corporation
of any certificate or certificates evidencing any securities, the Corporation at
its expense will issue in exchange therefor, and deliver to such holder new
certificates in such denomination or denominations as may be requested by such
holder. Upon receipt of evidence reasonably satisfactory to the Corporation of
the loss, theft, destruction or mutilation of any security issued by it and in
case of any such loss, theft or destruction, upon delivery of an indemnity
agreement reasonably satisfactory to the Corporation of any such mutilation,
upon surrender and cancellation of such security, the Corporation at its expense
will issue and deliver to any such holder a new security of like tenor, in lieu
of such lost, stolen, destroyed or mutilated certificate. 9.18 Entire Agreement.
This Agreement (including the exhibits hereto) and the other Transaction
Documents constitute the full and entire understanding and agreement between the
parties with respect to the subject matter hereof, and any other written or oral
agreement relating to the subject matter hereof existing between the parties are
expressly canceled.

--------------------------------------------------------------------------------

 
[exh101agreement037.jpg]
32 9.19 Interpretation. For purposes of this Agreement, (a) the words “include,”
“includes” and “including” shall be deemed to be followed by the words “without
limitation”; (b) the word “or” is not exclusive; and (c) the words “herein,”
“hereof,” “hereby,” “hereto” and “hereunder” refer to this Agreement as a whole.
Unless the context otherwise requires, references herein: (x) to Articles,
Sections, Exhibits and Schedules mean the Articles and Sections of, and Exhibits
and Schedules attached to, this Agreement; (y) to an agreement, instrument or
other document means such agreement, instrument or other document as amended,
supplemented and modified from time to time to the extent permitted by the
provisions thereof and (z) to a statute means such statute as amended from time
to time and includes any successor legislation thereto and any regulations
promulgated thereunder. This Agreement shall be construed without regard to any
presumption or rule requiring construction or interpretation against the party
drafting an instrument or causing any instrument to be drafted. The Schedules
referred to herein shall be construed with, and as an integral part of, this
Agreement to the same extent as if they were set forth verbatim herein. 9.20
Further Assurances. Each party hereto agrees to execute and deliver, by the
proper exercise of its corporate, limited liability company, partnership or
other powers, all such other and additional instruments and documents and do all
such other acts and things as may be necessary to more fully effectuate this
Agreement. [Signature Pages Follow]

--------------------------------------------------------------------------------

 
[exh101agreement038.jpg]
SIGNATURE PAGE TO PURCHASE AGREEMENT IN WITNESS WHEREOF, the parties have
executed this Series A-1 Preferred Stock Purchase Agreement as of the date first
written above. CORPORATION: FINJAN HOLDINGS, INC. By: Name: Title: PURCHASER:
SORYN HLDR VEHICLE II LLC By: Name: Title:

--------------------------------------------------------------------------------

 
[exh101agreement039.jpg]
EXHIBITS EXHIBIT A - FORM OF WARRANT EXHIBIT B - FORM OF CERTIFICATE OF
DESIGNATION

--------------------------------------------------------------------------------

 
[exh101agreement040.jpg]
EXHIBIT A FORM OF WARRANT (See attached)

--------------------------------------------------------------------------------

 
[exh101agreement041.jpg]
EXHIBIT B FORM OF CERTIFICATE OF DESIGNATION (See attached)

--------------------------------------------------------------------------------

 
[exh101agreement042.jpg]
ANNEX A LITIGATION 1. Finjan, Inc. v. FireEye, Inc., 4:13-cv-03133-SBA, (N.D.
Cal). 2. Finjan, Inc. v. Blue Coat Systems, Inc., Case 5:13-cv-03999-BLF, (N.D.
Cal.). 3. Finjan, Inc. v. Symantec Corporation, Case 3:14-cv-02998-HSG (N.D.
Cal.). 4. Finjan, Inc. v. Palo Alto Networks, Inc., Case 3:14-cv-04908-PJH (N.D.
Cal.). 5. Finjan, Inc. v. Blue Coat Systems, Inc., Case 5:15-cv-03295-BLF (N.D.
Cal.). 6. Finjan, Inc. v. ESET, LLC et al, Case 3:16-cv-00183-CAB (S.D. Cal) 7.
Finjan, Inc. v. Cisco Systems, Inc., Case 5:17-cv-00072-BLF (N.D. Cal.)

--------------------------------------------------------------------------------

 
[exh101agreement043.jpg]
ANNEX B PATENTS The following table sets forth, as of the date hereof, a brief
description of the Corporation’s issued U.S. patents, including their respective
issued patent numbers, filing dates, issue dates, expiration dates and titles
(collectively, the “Patents”) U.S. Patent No. Title 6,092,194 System and Method
for Protecting a Computer and a Network from Hostile Downloadables 6,154,844
System and Method for Attaching a Downloadable Security Profile to a
Downloadable 6,804,780 System and Method for Protecting a Computer and a Network
from Hostile Downloadables 6,965,968 Policy-Based Caching 7,058,822 Malicious
Mobile Code Runtime Monitoring System and Methods 7,418,731 Method and System
for Caching at Secure Gateways 7,613,918 System and Method for Enforcing a
Security Context on a Downloadable 7,613,926 Method and System for Protecting a
Computer and a Network from Hostile Downloadables 7,647,633 Malicious Mobile
Code Runtime Monitoring System and Methods 7,756,996 Embedding Management Data
Within HTTP Messages 7,757,289 System and Method for Inspecting Dynamically
Generated Executable Code 7,769,991 Automatically Executing an Anti-Virus
Application on a Mobile Communication Device 7,930,299 System and Method for
Appending Security Information to Search Engine Results 7,975,305 Method and
System for Adaptive Rule-Based Content Scanners for Desktop Computers 8,015,182
System and Method for Appending Security Information to Search Engine Results
8,079,086 Malicious Mobile Code Runtime Monitoring System and Methods 8,087,079
Byte-Distribution Analysis of File Security 8,141,154 System and Method for
Inspecting Dynamically Generated Executable Code 8,225,408 Method and System for
Adaptive Rule-Based Content Scanners 8,474,048 Website Content Regulation
8,566,580 Splitting an SSL Connection Between Gateways 8,677,494 Malicious
Mobile Code Runtime Monitoring System and Methods 9,141,786 Malicious Mobile
Code Runtime Monitoring System and Methods 9,189,621 Malicious Mobile Code
Runtime Monitoring System and Methods 9,219,755 Malicious Mobile Code Runtime
Monitoring System and Methods 9,294,493 Computer Security Method and System with
Input Parameter Validation 9,444,844 Malicious Mobile Code Runtime Monitoring
System and Methods 9,525,680 Splitting an SSL Connection Between Gateways

--------------------------------------------------------------------------------